Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. The company is headquartered in Hercules, California and currently employs 7,450 full-time employees. The firm offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. The company operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
What is Bio Rad Laboratories Inc (BIO)'s P/E Ratio?
The P/E ratio of Bio Rad Laboratories Inc is 9.2287
Who is the CEO of Bio Rad Laboratories Inc?
Mr. Norman Schwartz is the Chairman of the Board of Bio Rad Laboratories Inc, joining the firm since 1995.
What is the price performance of BIO stock?
The current price of BIO is $272, it has decreased 0.04% in the last trading day.
What are the primary business themes or industries for Bio Rad Laboratories Inc?
Bio Rad Laboratories Inc belongs to Life Sciences Tools & Services industry and the sector is Health Care
What is Bio Rad Laboratories Inc market cap?
Bio Rad Laboratories Inc's current market cap is $7.3B
Is Bio Rad Laboratories Inc a buy, sell, or hold?
According to wall street analysts, 7 analysts have made analyst ratings for Bio Rad Laboratories Inc, including 2 strong buy, 6 buy, 3 hold, 0 sell, and 2 strong sell